期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 896, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2021.173916
关键词
Atherosclerosis; Hydrogen sulfide; Gut microbiota; Inflammation
资金
- National Natural Science Foundation of China [81670429, 91839103]
- International Joint Laboratory for Arteriosclerotic Disease of Hunan Province [2018WK4031]
- Special Funding for Construction of Innovative Provinces in Hunan Province [2020SK2105]
- Double First-Class project for innovative Group of Basic Medicine, University of South China
Cardiovascular diseases, particularly atherosclerotic cardiovascular disease (ASCVD), are heavily influenced by environmental and genetic factors. Disruption of the human gut flora microenvironment is associated with various health problems, while hydrogen sulfide (H2S) plays crucial regulatory roles in the cardiovascular system, offering potential therapeutic direction for atherosclerosis.
Cardiovascular diseases are the leading cause of death and morbidity worldwide. Atherosclerotic cardiovascular disease (ASCVD) is affected by both environmental and genetic factors. Microenvironmental disorders of the human gut flora are associated with a variety of health problems, not only gastrointestinal diseases, such as inflammatory bowel disease, but also extralintestinal organs. Hydrogen sulfide (H2S) is the third gas signaling molecule other than nitric oxide and carbon monoxide. In the cardiovascular system, H2S plays important roles in the regulation of blood pressure, angiogenesis, smooth muscle cell proliferation and apoptosis, anti-oxidative stress, cardiac functions. This review is aiming to explore the potential role of gut microbiota in the development of atherosclerosis through hydrogen sulfide production as a novel therapeutic direction for atherosclerosis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据